Effect of the monotherapy of sitagliptin on glycemic control of patients with type 2 diabetes in different duration

Diabetes Metab Syndr. 2017 Dec:11 Suppl 2:S821-S825. doi: 10.1016/j.dsx.2017.07.001. Epub 2017 Jul 13.
No abstract available

Keywords: Blood glucose; Diabetes duration; Sitagliptin; β-cell function.

MeSH terms

  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / pharmacology
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Male
  • Middle Aged
  • Risk Reduction Behavior
  • Sitagliptin Phosphate / pharmacology
  • Sitagliptin Phosphate / therapeutic use*
  • Treatment Outcome

Substances

  • Blood Glucose
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human
  • Sitagliptin Phosphate